Author:
Xiong Yiyi,Xu Jiawei,Zhang Deju,Wu Shuqin,Li Zhangwang,Zhang Jing,Xia Zhongbin,Xia Panpan,Xia Cai,Tang Xiaoyi,Liu Xiao,Liu Jianping,Yu Peng
Abstract
Kawasaki disease (KD) is an acute autoimmune vascular disease featured with a long stage of febrile. It predominantly afflicts children under 5 years old and causes an increased risk of cardiovascular combinations. The onset and progression of KD are impacted by many aspects, including genetic susceptibility, infection, and immunity. In recent years, many studies revealed that miRNAs, a novel class of small non-coding RNAs, may play an indispensable role in the development of KD via differential expression and participation in the central pathogenesis of KD comprise of the modulation of immunity, inflammatory response and vascular dysregulation. Although specific diagnose criteria remains unclear up to date, accumulating clinical evidence indicated that miRNAs, as small molecules, could serve as potential diagnostic biomarkers and exhibit extraordinary specificity and sensitivity. Besides, miRNAs have gained attention in affecting therapies for Kawasaki disease and providing new insights into personalized treatment. Through consanguineous coordination with classical therapies, miRNAs could overcome the inevitable drug-resistance and poor prognosis problem in a novel point of view. In this review, we systematically reviewed the existing literature and summarized those findings to analyze the latest mechanism to explore the role of miRNAs in the treatment of KD from basic and clinical aspects retrospectively. Our discussion helps to better understand the pathogenesis of KD and may offer profound inspiration on KD diagnosis, treatment, and prognosis.
Funder
Natural Science Foundation of Jiangxi Province
National Natural Science Foundation of China
Subject
Immunology,Immunology and Allergy
Reference146 articles.
1. Kawasaki Disease, autoimmune disorders, and cancer: a register-based study;Nielsen;Eur J pediatrics,2021
2. Kawasaki Disease: Origins and evolution;Kainth;Arch Dis childhood,2021
3. Diagnosis and management of kawasaki disease;Saguil;Am Family physician,2015
4. Kawasaki Disease recognition and treatment;Morishita;Can Family physician Medecin famille canadien,2020
5. Intestinal involvement in Kawasaki disease;Colomba;J pediatrics,2018
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献